Transmedics Group Stock Technical Analysis
| TMDX Stock | USD 129.61 -10.46 -7.47% |
As of the 9th of March, the last recorded price for TransMedics is 129.61 per share. Primary technical drivers reflect Variance of 8.26, coefficient of variation of -1,557, and Risk Adjusted Performance of -0.04. Quantitative analysis incorporates volatility metrics and price behavior to assess directional bias. Metrics are compared to industry averages to assess relative positioning.
TransMedics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as TransMedics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TransMedicsTransMedics | Build AI portfolio with TransMedics Stock |
TransMedics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 157.55 | Strong Buy | 9 | Odds |
TransMedics Group current and past analyst recommendations are summarized from multiple research sources. Average analyst consensus is included for context. Analyst ratings for TransMedics Group aggregate the views of institutional research teams who conduct deep fundamental analysis, build financial models, and speak directly with TransMedics's management. Consensus upgrades or downgrades often have meaningful short-term impact on the stock price.
Quarterly Earnings Growth 11.881 | Earnings Share 4.87 | Revenue Per Share | Quarterly Revenue Growth 0.322 | Return On Assets |
The market value of TransMedics Group is measured differently than book value, which reflects TransMedics accounting equity. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Market price responds to sentiment, liquidity, and macro shifts, so gaps can appear. Valuation work aligns these measures into a single context.
Note that TransMedics' intrinsic value and market price are different measures derived from different inputs. Context can include financial performance, operating efficiency, market trends, and peer comparisons. Trading price represents the transaction level agreed by market participants.
TransMedics 'What if' Analysis
Running a what-if backtest on TransMedics Group gives investors a practical way to test how changes in horizon, position size, or market timing might have affected the result. Used properly, this review helps investors decide whether TransMedics' historical reward profile was stable enough to support the current thesis.
| 12/09/2025 |
| 03/09/2026 |
If you invested 0.00 in TransMedics on December 9, 2025 and closed the position today, you would earn 0.00 in aggregate gains. The change equals a 0.0% return on investment in TransMedics on balance over a 90 day window.. TransMedics is related to or competes with Option Care, Glaukos Corp, Oscar Health, Immunovant, Kymera Therapeutics, NewAmsterdam Pharma, and Indivior PLC. Peer context can support comparative analysis. TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy... More
TransMedics Upside and Downside Indicators Signals
Upside and downside indicators for TransMedics summarize momentum balance and potential range context for the stock. The signals are presented as informational context for recent price movement.
| Information Ratio | -0.07 | |||
| Maximum Drawdown | 13.08 | |||
| Value At Risk | -5.14 | |||
| Potential Upside | 5.06 |
TransMedics Market Risk Indicators Signals
Market risk indicators summarize volatility and return dispersion for TransMedics. This view provides neutral context for risk and variability.| Risk Adjusted Performance | -0.04 | |||
| Jensen Alpha | -0.19 | |||
| Total Risk Alpha | -0.19 | |||
| Treynor Ratio | -0.41 |
The concept of mean reversion suggests that TransMedics' price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
TransMedics Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.04 | |||
| Market Risk Adjusted Performance | -0.40 | |||
| Mean Deviation | 2.16 | |||
| Coefficient Of Variation | -1,557 | |||
| Standard Deviation | 2.87 | |||
| Variance | 8.26 | |||
| Information Ratio | -0.07 | |||
| Jensen Alpha | -0.19 | |||
| Total Risk Alpha | -0.19 | |||
| Treynor Ratio | -0.41 | |||
| Maximum Drawdown | 13.08 | |||
| Value At Risk | -5.14 | |||
| Potential Upside | 5.06 | |||
| Skewness | 0.1465 | |||
| Kurtosis | 0.6321 |
TransMedics Group Backtested Returns
Over the selected 3 months, TransMedics demonstrates a very low volatility profile. It shows a risk-adjusted return measure of close to zero, defining negative risk-normalized returns. We identified twenty-four technical indicators influencing the company's volatility profile. Please analyze metrics such as Variance of 8.26, risk-adjusted performance of -0.04, and Coefficient Of Variation of -1,557 to assess dispersion and downside exposure. The company owns a Beta (Systematic Risk) of 0.47, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, TransMedics' returns are expected to increase less than the market. However, during the bear market, the loss of holding TransMedics is expected to be smaller as well. At this point, TransMedics Group has a negative expected return of -0.0234%. Please make sure to confirm TransMedics' the relationship between the daily balance of power and period momentum indicator , to decide if TransMedics Group performance from the past will be repeated in the future.
Auto-correlation | 0.47 |
Average predictability
TransMedics Group exhibits average predictability. Autocorrelation measures the degree of predictability between TransMedics time series from 9th of December 2025 to 23rd of January 2026 and from 23rd of January 2026 to 9th of March 2026. The stronger the relationship between the current interval and its lagged values, the more accurately future price behavior of TransMedics Group may be projected. A serial correlation of 0.47 indicates that about 47.0% of current TransMedics price fluctuations can be explained by its historical price movements.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 28.11 |
TransMedics technical stock analysis uses price and volume transformations to study behavior. The model references moving averages, relative strength, and price correlation signals.
TransMedics Group Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of TransMedics Group volatility. High ATR values indicate high volatility, and low values indicate low volatility.
TransMedics Technical Analysis Overview
Technical analysis of TransMedics evaluates price structure, momentum, and volatility clustering. Volume and liquidity conditions influence signal reliability. Lower liquidity may increase execution variability. We review the company from a portfolio-construction standpoint emphasizing diversification and stability.
Methodology
Unless otherwise specified, financial data for TransMedics Group is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. TransMedics (USA Stocks:TMDX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Technical and fundamental diagnostic scores are rule-based values computed from historical price and fundamental inputs.
Assumptions
Inputs rely on public filings and market reference sources and institutional disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Publication cadence can introduce timing differences. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
TransMedics Group may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
TransMedics Technical Indicators
A technical review of TransMedics Group can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.04 | |||
| Market Risk Adjusted Performance | -0.40 | |||
| Mean Deviation | 2.16 | |||
| Coefficient Of Variation | -1,557 | |||
| Standard Deviation | 2.87 | |||
| Variance | 8.26 | |||
| Information Ratio | -0.07 | |||
| Jensen Alpha | -0.19 | |||
| Total Risk Alpha | -0.19 | |||
| Treynor Ratio | -0.41 | |||
| Maximum Drawdown | 13.08 | |||
| Value At Risk | -5.14 | |||
| Potential Upside | 5.06 | |||
| Skewness | 0.1465 | |||
| Kurtosis | 0.6321 |
TransMedics March 9, 2026 Daily Trend Indicators
A technical review of TransMedics Group can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Accumulation Distribution | 0.07 | ||
| Daily Balance Of Power | -1.16 | ||
| Rate Of Daily Change | 0.93 | ||
| Day Median Price | 133.27 | ||
| Day Typical Price | 132.05 | ||
| Price Action Indicator | -8.89 | ||
| Market Facilitation Index | 9.03 |
Popular Tools for TransMedics Stock analysis
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |